Author:
Wang Jing,Hu Yingying,Li Qingqing,Liu Ya-nan,Lin Jingjing,Xu Ren-ai
Reference35 articles.
1. ACC/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison;Capodanno;J. Am. Coll. Cardiol.,2018
2. A review of the role of the antiplatelet drug ticagrelor in the management of acute coronary syndrome, acute thrombotic disease, and other diseases;Tao;Med. Sci. Mon. Int. Med. J. Exp. Clin. Res. : Int. Med. J. Exp. Clin. Res.,2022
3. Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety;Dobesh;Pharmacotherapy,2014
4. Ticagrelor: a review of its use in adults with acute coronary syndromes;Dhillon;Am. J. Cardiovasc. Drugs Drugs Dev Other Interventions,2015
5. Ticagrelor, prasugrel, or clopidogrel in ST-segment elevation myocardial infarction: which one to choose?;Guimarães;Expet Opin. Pharmacother.,2015